| Capturing and profiling adult hair follicle stem cells | Nature Biotechnology | 2004 | 1K |
| Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial | Circulation | 2011 | 872 |
| Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy | Nature Medicine | 2005 | 860 |
| Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses | Cancer Research | 2007 | 492 |
| Aryl hydrocarbon receptor control of a disease tolerance defence pathway | Nature | 2014 | 436 |
| J wave syndromes | Heart Rhythm | 2010 | 425 |
| Enrichment for living murine keratinocytes from the hair follicle bulge with the cell surface marker CD34 | Journal of Investigative Dermatology | 2003 | 422 |
| Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial | Circulation | 2012 | 409 |
| Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan | Cancer Research | 2007 | 395 |
| DNA repair mediated by endonuclease-independent LINE-1 retrotransposition | Nature Genetics | 2002 | 352 |
| Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study) | American Journal of Cardiology | 2007 | 339 |
| Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial | Stroke | 2012 | 333 |
| Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial | Lancet Neurology, The | 2010 | 329 |
| Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer | Cancer Immunology, Immunotherapy | 2014 | 328 |
| Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes | Blood | 2009 | 326 |
| Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape | Immunological Reviews | 2008 | 325 |
| Discovery of IDO1 Inhibitors: From Bench to Bedside | Cancer Research | 2017 | 322 |
| Enrichment for murine keratinocyte stem cells based on cell surface phenotype | Proceedings of the National Academy of Sciences of the United States of America | 2000 | 314 |
| Classification of current anticancer immunotherapies | Oncotarget | 2014 | 301 |
| Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial | Circulation | 2009 | 299 |
| Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy | Circulation | 2012 | 291 |
| Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II Registry | Journal of the American College of Cardiology | 2016 | 291 |
| Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models | Cell Death and Disease | 2012 | 290 |
| Is beta-galactosidase staining a marker of senescence in vitro and in vivo? | Experimental Cell Research | 2000 | 288 |
| Occludin: structure, function and regulation | Advanced Drug Delivery Reviews | 2005 | 286 |
